Current Update of Cytokines in Pancreatic Cancer: Pathogenic Mechanisms, Clinical Indication, and Therapeutic Values

REFERENCES

• Chada S., Bocangel D., Ramesh R., Grimm E. A., Mumm J. B., et al. mda-7/IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer. Mol. Ther. 2005; 11: 724–33, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ebrahimi B., Tucker S. L., Li D., Abbruzzese J. L., Kurzrock R. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer 2004; 101: 2727–2736, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Feijoo E., Alfaro C., Mazzolini G., Serra P., Penuelas I., Arina A., Huarte E., Tirapu I., Palencia B., Murillo O., Ruiz J., Sangro B., Richter J. A., Prieto J., Melero I. Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8. Int. J. Cancer 2005; 116: 275–281, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• McDade T. P., Perugini R. A., Vittimberga F. J., Jr., Carrigan R. C., Callery M. P. Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells. J. Surg. Res. 1999; 83: 56–61, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ryu B., Jones J., Hollingsworth M. A., Hruban R. H., Kern S. E. Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. Cancer Res. 2001; 61: 1833–1838, [INFOTRIEVE], [CSA]
   Web of Science ®Google Scholar
• Oppenheim J. J. Introduction to the Role of Cytokines in Innate Host Defense and Adaptive Immunity, Feldman, Marc 2000, posting date. [Online.]
   Google Scholar
• Goldsby R. A., Goldsby K. T. J., Barbara O. A. Immunology, 4th edition. W.H. Freeman and Co. 2000
   Google Scholar
• Duram S. K. Cytokines and the Immune System. 2000, (Online)
   Google Scholar
• Tsuzuki Y., Mouta Carreira C., Bockhorn M., Xu L., Jain R. K., Fukumura D. Pancreas microenvironment promotes VEGF expression and tumor growth: novel window models for pancreatic tumor angiogenesis and microcirculation. Lab. Invest. 2001; 81: 1439–1451, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Wenger C., Ellenrieder V., Alber B., Lacher U., Menke A., Hameister H., Wilda M., Iwamura T., Beger H. G., Adler G., Gress T. M. Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene. 1999; 18: 1073–1080, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Dvorak H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 1986; 315: 1650–1659, [CSA]
   Google Scholar
• McCawley L. J., Matrisian L. M. Tumor progression: defining the soil round the tumor seed. Curr. Biol. 2001; 11: R25–R27, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Farrow B., Sugiyama Y., Chen A., Uffort E., Nealon W., Mark Evers B. Inflammatory mechanisms contributing to pancreatic cancer development. Ann. Surg. 2004; 239: 763–769, discussion 769–771[INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kleeff J., Kusama T., Rossi D. L., Ishiwata T., Maruyama H., Friess H., Buchler M. W., Zlotnik A., Korc M. Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int. J. Cancer 1999; 81: 650–657, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kuwada Y., Sasaki T., Morinaka K., Kitadai Y., Mukaida N., Chayama K. Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells. Int. J. Oncol. 2003; 22: 765–771, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Xiong Q., Shi Q., Le X., Wang B., Xie K. Regulation of interleukin-8 expression by nitric oxide in human pancreatic adenocarcinoma. J. Interferon. Cytokine. Res. 2001; 21: 529–537, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Muerkoster S., Wegehenkel K., Arlt A., Witt M., Sipos B., Kruse M. L., Sebens T., Kloppel G., Kalthoff H., Folsch U. R., Schafer H. Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. Cancer Res. 2004; 64: 1331–1337, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Marchesi F., Monti P., Leone B. E., Zerbi A., Vecchi A., Piemonti L., Mantovani A., Allavena P. Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res. 2004; 64: 8420–8427, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Macura-Biegun A., Ruggiero I., Hajto B., Zembala M. Extracellular matrix proteins modulate cytokine production by monocytes during their interactions with cancer cells. Anticancer. Res. 2003; 23: 4033–4038, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Prokopchuk O., Liu Y., Henne-Bruns D., Kornmann M. Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions. Br. J. Cancer 2005; 92: 921–928, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Takamori H., Oades Z. G., Hoch O. C., Burger M., Schraufstatter I. U. Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1. Pancreas 2000; 21: 52–56, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Miyamoto M., Shimizu Y., Okada K., Kashii Y., Higuchi K., Watanabe A. Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells. Cancer Immunol. Immunother. 1998; 47: 47–57, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Friess H., Guo X. Z., Nan B. C., Kleeff O., Buchler M. W. Growth factors and cytokines in pancreatic carcinogenesis. Ann. N. Y. Acad. Sci. 1999; 880: 110–121, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kalthoff H., Roeder C., Brockhaus M., Thiele H. G., Schmiegel W. Tumor necrosis factor (TNF) up-regulates the expression of p75 but not p55 TNF receptors, and both receptors mediate, independently of each other, up-regulation of transforming growth factor alpha and epidermal growth factor receptor mRNA. J. Biol. Chem. 1993; 268: 2762–2766, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Greten F. R., Wagner M., Weber C. K., Zechner U., Adler G., Schmid R. M. TGF alpha transgenic mice. A model of pancreatic cancer development. Pancreatology 2001; 1: 363–368, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hallahan D., Beckett M. A., Kufe D., et al. The interaction between recombinant human tumor necrosis factor and raiation in 13 human tumor cell lines. Int. J. Radiat. Oncol. Biol. Phys. 1990; 19: 69–74, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hallahan D., Vokes E. E., Rubin S. J., et al. Phase I dose-escalation study of Tumor Necrosis Factor-alpha and concomitant radiation therapy. Cancer J. Sci. Am. 1995; 1: 204, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Hanna N., Chung T., Hecht J. R., et al. Presented at the 41st Annual Meeting of The American Society of Clinical Oncology, Orlando, Florida, May, 13–17, 2005
   Google Scholar
• Blanchard J. A., 2nd, Barve S., Joshi-Barve S., Talwalker R., Gates L. K., Jr. Cytokine production by CAPAN-1 and CAPAN-2 cell lines. Dig. Dis. Sci. 2000; 45: 927–932, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Wigmore S. J., Fearon K. C., Sangster K., Maingay J. P., Garden O. J., Ross J. A. Cytokine regulation of constitutive production of interleukin-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer. Int. J. Oncol. 2002; 21: 881–886, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Takaya H., Andoh A., Shimada M., Hata K., Fujiyama Y., Bamba T. The expression of chemokine genes correlates with nuclear factor-kappaB activation in human pancreatic cancer cell lines. Pancreas 2000; 21: 32–40, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sclabas G. M., Fujioka S., Schmidt C., Li Z., Frederick W. A., Yang W., Yokoi K., Evans D. B., Abbruzzese J. L., Hess K. R., Zhang W., Fidler I. J., Chiao P. J. Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. Clin. Cancer Res. 2005; 11: 440–449, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Masui T., Hosotani R., Doi R., Miyamoto Y., Tsuji S., Nakajima S., Kobayashi H., Koizumi M., Toyoda E., Tulachan S. S., Imamura M. Expression of IL-6 receptor in pancreatic cancer: involvement in VEGF induction. Anticancer. Res. 2002; 22: 4093–4100, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Matsuo Y., Sawai H., Funahashi H., Takahashi H., Sakamoto M., Yamamoto M., Okada Y., Hayakawa T., Manabe T. Enhanced angiogenesis due to inflammatory cytokines from pancreatic cancer cell lines and relation to metastatic potential. Pancreas. 2004; 28: 344–352, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Le X., Shi Q., Wang B., Xiong Q., Qian C., Peng Z., Li X. C., Tang H., Abbruzzese J. L., Xie K. Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma. J. Interferon. Cytokine. Res. 2000; 20: 935–946, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Farrow B., Evers B. M. Inflammation and the development of pancreatic cancer. Surg. Oncol. 2002; 10: 153–169, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Staba M., Mauceri H. J., Kufe D. W., et al. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft. Gene. Therapy. 1998; 5: 293–300, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Miyamoto Y., Hosotani R., Doi R., Wada M., Ida J., Tsuji S., Kawaguchi M., Nakajima S., Kobayashi H., Masui T., Imamura M. Interleukin-6 inhibits radiation induced apoptosis in pancreatic cancer cells. Anticancer. Res. 2001; 21: 2449–2456, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Yoshimura T., Leonard E. J. Secretion by human fibroblasts of monocyte chemoattractant protein-1, the product of gene JE. J. Immunol. 1990; 144: 2377–2383, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kimura M., Yoshida Y., Narita M., Takenaga K., Takenouchi T., Yamaguchi T., Saisho H., Sakiyama S., Tagawa M. Acquired immunity in nude mice induced by expression of the IL-2 or IL-4 gene in human pancreatic carcinoma cells and anti-tumor effect generated by in vivo gene transfer using retrovirus. Int. J. Cancer 1999; 82: 549–555, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kawakami K., Kawakami M., Husain S. R., Puri R. K. Targeting interleukin-4 receptors for effective pancreatic cancer therapy. Cancer Res. 2002; 62: 3575–3580, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kornmann M., Kleeff J., Debinski W., Korc M. Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by Pseudomonas exotoxin coupled to interleukin-13 and -4. Anticancer. Res. 1999; 19: 125–131, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kawakami K., Kawakami M., Husain S. R., Puri R. K. Potent antitumor activity of IL-13 cytotoxin in human pancreatic tumors engineered to express IL-13 receptor alpha2 chain in vivo. Gene. Ther. 2003; 10: 1116–1128, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Saito K., Ishikura H., Kishimoto T., Kawarada Y., Yano T., Takahashi T., Kato H., Yoshiki T. Interleukin-6 produced by pancreatic carcinoma cells enhances humoral immune responses against tumor cells: a possible event in tumor regression. Int. J. Cancer 1998; 75: 284–289, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Yoshida Y., Tasaki K., Kimurai M., Takenaga K., Yamamoto H., Yamaguchi T., Saisho H., Sakiyama S., Tagawa M. Antitumor effect of human pancreatic cancer cells transduced with cytokine genes which activate Th1 helper T cells. Anticancer. Res. 1998; 18: 333–335, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Motoi F., Sunamura M., Ding L., Duda D. G., Yoshida Y., Zhang W., Matsuno S., Hamada H. Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirus. Hum. Gene. Ther. 2000; 11: 223–235, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Putzer B. M., Rodicker F., Hitt M. M., Stiewe T., Esche H. Improved treatment of pancreatic cancer by IL-12 and B7.1 costimulation: antitumor efficacy and immunoregulation in a nonimmunogenic tumor model. Mol. Ther. 2002; 5: 405–412, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Stoeltzing O., Liu W., Reinmuth N., Fan F., Parikh A. A., Bucana C. D., Evans D. B., Semenza G. L., Ellis L. M. Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. Am. J. Pathol. 2003; 163: 1001–1011, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Hatanaka K., Suzuki K., Miura Y., Yoshida K., Ohnami S., Kitade Y., Yoshida T., Aoki K. Interferon-alpha and antisense K-ras RNA. combination gene therapy against pancreatic cancer. J. Gene. Med. 2004; 6: 1139–1148, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Nukui Y., Picozzi V. J., Traverso L. W. Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am. J. Surg. 2000; 179: 367–371, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Wagener D. J., Wils J. A., Kok T. C., Planting A., Couvreur M. L., Baron B. Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with alpha-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial. Eur. J. Cancer 2002; 38: 648–653, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Endou M., Mizuno M., Nagata T., Tsukada K., Nakahara N., Tsuno T., Osawa H., Kuno T., Fujita M., Hatano M., Yoshida J. Growth inhibition of human pancreatic cancer cells by human interferon-beta gene combined with gemcitabine. Int. J. Mol. Med. 2005; 15: 277–283, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar